CE-mark opens the door to billion-dollar market for orthopaedic trauma implants
Orthopaedic trauma implants in titanium with Bactiguard's coating for infection prevention have been CE marked and can, from now on, be sold and used in markets that apply EU quality standards. At the same time, the CE-mark opens possibilities for Bactiguard to establish new license agreements covering more markets. The global market for trauma implants is estimated at over 5 billion USD*."The CE mark we have now secured is a major breakthrough for Bactiguard. It is the first time our technology has been approved for use on metal implants, designed to stay in the body for months up to